Boudabous et al. collected 24 cases of GIST (confirmed by the positivity of CD117 and/or CD33) analyzing demographic characteristics, clinical pattern, investigations treatment and therapeutic variables of patients. This evidence concerns the gene CD33 and gastrointestinal stromal tumor.